The entire Hewlett-Packard Viridia CMS product family of patient monitors will soon be incorporated with an innovative bedside 12-lead ECG or electrocardiogram monitoring solution. During the 71st American Heart Association Scientific Sessions, which took place in Dallas, HP presented the future integration of the EASI acquisition software algorithm, licensed from Zymed Inc., as a work-in-progress. Running EASI on the HP Viridia CMS will enable clinicians and nurses to obtain permanent 12-lead ECG at the patient's bedside with no more than five electrodes.
For traditional 12-lead ECG monitoring at the patient's bedside, the nurse has to connect ten electrodes to the patient's body. In 1998, HP sponsored a inquiry within the American Association of Critical Care Nurses National Teaching Institute (AACN-NTI). Results showed that two-thirds out of 399 respondents experienced barriers to the conventional methods of 12-lead ECG monitoring. More than half of the respondents indicated the lack of sufficient nurses' training as the primary cause for defective 12-lead ECG monitoring because of ill-connected electrodes.
With the integration of the EASI software into the HP monitoring products, the company will be able to offer a comprehensive, yet practical and user-friendly 12-lead solution for improved patient care. It will allow nurses to obtain the required information in a way that is far more easy to implement whereas the patient will benefit from a much more comfortable treatment. The EASI 12-lead ECG system applies only five electrodes and three vectors. The software has already been used extensively within the Holter monitoring equipment of which Zymed is a leading provider in the United States.
The EASI 12-lead technology is equally applied in Zymed's telemetry solution which has been installed in over 1600 hospital beds all over the world. The Zymed company has been founded in 1981 as a developer of cardiac analysis software algorithms as well as inpatient and outpatient cardiac products. At present, HP Viridia CMS is not commercially available with EASI software yet. The new 12-lead ECG solution still needs further development, clinical testing and subsequent approval by the Food and Drug Administration (FDA) before entering the health care market.